Table 1 Correlation between circZNF566 expression and clinicopathological features in HCC tissues (n = 57, χ2-test).
N | CicrZNF566 | Expression | P-value | |
|---|---|---|---|---|
High (%) | Low (%) | |||
Age (year) | 0.520 | |||
<60 | 45 | 24 (53.3%) | 21 (46.7%) | |
≥60 | 12 | 8 (66.7%) | 4 (33.3%) | |
Gender | 0.092 | |||
Male | 46 | 26 (71.7%) | 20 (90.9%) | |
Female | 11 | 6 (55.5%) | 5 (45.5%) | |
Tumor number | 0.502 | |||
Single | 49 | 27 (55.1%) | 22 (44.9%) | |
Multiple | 8 | 5 (62.5%) | 3 (37.5%) | |
Tumor size | 0.035 | |||
<5 cm | 27 | 16 (59.3%) | 11 (40.7%) | |
≥5 cm | 30 | 21 (70.0%) | 9 (30.0%) | |
Tumor differentiation | 0.011 | |||
I–II | 37 | 16 (51.8%) | 21 (43.2%) | |
III–IV | 20 | 16 (80.0%) | 4 (20.0%) | |
Tumor location | 0.856 | |||
Left liver | 10 | 5 (50.0%) | 5 (50.0%) | |
Right liver | 42 | 25 (59.5%) | 17 (40.5%) | |
Whole liver | 5 | 3 (60.0%) | 2 (40.0%) | |
Vascular invasion | 0.085 | |||
Yes | 16 | 12 (75.0%) | 4 (25.0%) | |
No | 41 | 21 (51.2%) | 20 (48.8%) | |
Liver cirrhosis | 1.000 | |||
Yes | 29 | 17 (58.6%) | 12 (41.4%) | |
No | 28 | 16 (57.1%) | 12 (42.9%) | |
Hepatitis virus | 0.227 | |||
Yes | 6 | 4 (66.7%) | 2 (33.3%) | |
No | 51 | 31 (60.8%) | 20 (39.2%) | |
M stage | 0.016 | |||
M0 | 46 | 24 (52.2%) | 22 (47.8%) | |
M1 | 11 | 10 (90.9%) | 1 (9.1%) |
